Introduction
Patients and methods
A-EF (n = 5) No. of patients (%) | SFIF (n = 8) No. of patients (%) | PMMF (n = 9) No. of patients (%) | TIMF (n = 13) No. of patients (%) | P-value | |
---|---|---|---|---|---|
Sex | |||||
Male | 3 (80.0) | 5 (62.6) | 6 (66.7) | 7 (53.8) | 0.887a |
Female | 2 (20.0) | 3 (37.4) | 3 (33.3) | 6 (46.2) | |
Age, years (mean ± SD) | 52.0 ± 8.5 | 64.3 ± 9.2 | 59.6 ± 8.2 | 59.8 ± 12.7 | 0.863a |
Clinical stage | |||||
I | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.026b |
II | 5 (100.0) | 3 (22.5) | 0 (0.0) | 0 (0.0) | |
III + rCS III | 0 (0.0) | 5 (42.5) | 5 + 1 (66.7) | 1 + 6 (53.8) | |
IV + rCS IV | 0 (0.0) | 0 (0.0) | 2 + 1 (33.3) | 4 + 2 (46.2) | |
Treatment | |||||
TR | 5 (100.0) | 7 (87.5) | 3 (33.3) | 0 (0.0) | 0.036b |
TR + PM + MM | 0 (0.0) | 1 (12.5) | 5 (55.6) | 8 (61.5) | |
TR + Man+Max | 0 (0.0) | 0 (0.0) | 1 (11.1) | 5 (38.5) | |
Flap (cm) | |||||
Inner dimensions | |||||
Range, median | 1 × 2 to 2 × 3, 1.8 × 2.2 | 5 × 3 to 7 × 5, 5.5 × 4.3 | 6 × 4 to 7 × 5, 6.3 × 4.5 | 6 × 6 to 15 × 8, 9.8 × 6.7 | 0.041b |
Outer dimensions | |||||
Range, median | 2 × 2 to 3 × 5, 1.8 × 3.8 | 5 × 4 to 7 × 8, 5.5 × 4.6 | 6 × 6 to 7 × 6, 6.3 × 6.6 | 6 × 8 to 15 × 20, 9.8 × 13.2 | 0.033b |
Successful (no.) | 5 (100.0) | 7 (87.5) | 9(100.0) | 13 (100.0) | 0.967a |
Local complications | |||||
Hemorrhage | 1 (20.0) | 1 (12.5) | 0 (0.0) | 1 (7.7) | 0.554c |
Orocutaneous fistula | 0 (0.0) | 1 (12.5) | 0 (0.0) | 0 (0.0) | |
Dehiscence in donor-site | 0 (0.0) | 0 (0.0) | 1 (11.1) | 2 (15.4) | |
Esthetic results | |||||
1 | 0 (0.0) | 1 (12.5) | 1 (11.1) | 4 (30.8) | 0.039c |
2 | 1 (20.0) | 2 (25.0) | 6 (66.7) | 7 (53.8) | |
3 | 4 (80.0) | 5 (62.5) | 2 (22.2) | 2 (15.4) | |
Orbicularis oris function | |||||
1 | 0 (0.0) | 1 (12.5) | 2 (22.2) | 4 (30.8) | 0.042c |
2 | 0 (0.0) | 1 (12.5) | 4 (44.5) | 6 (46.2) | |
3 | 5 (100.0) | 6 (75.0) | 3 (33.3) | 3 (23.0) | |
Speech function | |||||
1 | 0 (0.0) | 0 (0.0) | 2 (22.2) | 5 (38.4) | 0.046c |
2 | 0 (0.0) | 2 (25.0) | 3 (33.3) | 6 (46.2) | |
3 | 5 (100.0) | 6 (75.0) | 4 (44.5.) | 2 (15.4) | |
Follow-up range, median (months) | 6–38, 26.8 | 6–36, 25.0 | 6–32, 22.1 | 6–33, 20.8 | 0.829a |
Status (months) | |||||
AND | 4 (80.0) | 7 (87.5) | 5 (55.6) | 5 (38.4) | 0.039b |
AWD | 1 (20.0) | 1 (12.5) | 2 (22.2) | 4 (30.8) | |
DOD | 0 (0.0) | 0 (0.0) | 2 (22.2) | 4 (30.8) |